Bladder cancer trials in Singapore
2 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1/2RecruitingTrial-stage medicine
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Where
- Singapore
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT04198766Registry updated 2026-11-06
Phase 1/2RecruitingTrial-stage medicine
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Where
- Singapore
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Alentis Therapeutics AG
See details and how to joinNCT07169734EU 2025-521441-24-00Registry updated 2026-07-02
All Bladder cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.